(Q37824291)

23 August 2017

1 reference

title

Coreceptors and HIV-1 pathogenesis (English)

1 reference

23 August 2017

0 references

0 references

2

Petronela Ancuta

1 reference

23 August 2017

Paul R Gorry

1

1 reference

23 August 2017

publication date

1 March 2011

1 reference

23 August 2017

published in

Current HIV/AIDS reports

1 reference

23 August 2017

volume

8

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

45-53

1 reference

An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Evolution of CCR5 use before and during coreceptor switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

The neuropathogenesis of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Emerging concepts in the immunopathogenesis of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Th17 lineage commitment and HIV-1 pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Targeting early infection to prevent HIV-1 mucosal transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

The precursors of memory: models and controversies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Host hindrance to HIV-1 replication in monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Quantitative 3D video microscopy of HIV transfer across T cell virological synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0069-X

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection

21 January 2018

1 reference

12 December 2020

Nomenclature of monocytes and dendritic cells in blood.

1 reference

12 December 2020

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.

1 reference

12 December 2020

A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5

1 reference

12 December 2020

Editorial: Monocyte subpopulations and lentiviral infection

1 reference

12 December 2020

10.1007/S11904-010-0069-X

Identifiers

DOI

1 reference

23 August 2017

1 reference